Foster City, CA, United States of America

Jie Xu

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 371(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jie Xu: A Pioneer in Cancer Research

Introduction: Jie Xu, based in Foster City, California, has established himself as a prominent figure in the field of cancer research with an impressive portfolio of 20 patents to his name. His work primarily focuses on developing novel compounds and methods that have the potential to transform cancer therapies and address viral infections.

Latest Patents: Among Jie Xu's notable contributions are his groundbreaking patents for PD-1/PD-L1 inhibitors. These patents encompass innovative compounds and methods for using such compounds, either alone or in combination with additional agents, for treating cancer. Another significant patent involves diacylglycerol kinase modulating compounds, which offer promising pharmaceutical compositions for treating not only solid tumors but also viral infections, including HIV and hepatitis B. The versatility of these compounds allows for their application both independently and in conjunction with other therapeutic agents.

Career Highlights: Jie Xu has had a distinguished career, having worked at leading companies such as Gilead Sciences, Inc. and Facebook, Inc. His experience at these organizations has allowed him to contribute to pioneering research and innovation in the biotechnology and pharmaceutical sectors.

Collaborations: Throughout his career, Jie Xu has collaborated with esteemed colleagues, including Aesop Cho and Michael Graupe. These partnerships have enabled him to leverage diverse expertise and share insights that drive forward the frontiers of cancer treatment and research.

Conclusion: Jie Xu stands out as a dedicated innovator in the realm of cancer research. His extensive patent portfolio and collaborative efforts with other professionals highlight his commitment to advancing medical science and improving patient outcomes. As he continues his work, the impact of his inventions and innovations will undoubtedly resonate in the field of oncology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…